Janus Henderson Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Hold |
58,800
| – | – | ﹤0.01% | 1981 |
|
|
2025
Q1 | $486K | Hold |
58,800
| – | – | ﹤0.01% | 1971 |
|
|
2024
Q4 | $466K | Hold |
58,800
| – | – | ﹤0.01% | 2067 |
|
|
2024
Q3 | $489K | Hold |
58,800
| – | – | ﹤0.01% | 2045 |
|
|
2024
Q2 | $374K | Sell |
58,800
-570
| -1% | -$3.62K | ﹤0.01% | 2108 |
|
|
2024
Q1 | $359K | Buy |
59,370
+41
| +0.1% | +$248 | ﹤0.01% | 2159 |
|
|
2023
Q4 | $360K | Buy |
+59,329
| New | +$360K | ﹤0.01% | 2143 |
|
|
2023
Q2 | – | Sell |
-44,720
| Closed | -$62.6K | – | 2596 |
|
|
2023
Q1 | $62.6K | Buy |
44,720
+24,979
| +127% | +$35K | ﹤0.01% | 2647 |
|
|
2022
Q4 | $39.2K | Sell |
19,741
-19,739
| -50% | -$39.2K | ﹤0.01% | 2434 |
|
|
2022
Q3 | $80K | Buy |
39,480
+19,705
| +100% | +$39.9K | ﹤0.01% | 2500 |
|
|
2022
Q2 | $63K | Buy |
19,775
+49
| +0.2% | +$156 | ﹤0.01% | 2531 |
|
|
2022
Q1 | $83K | Buy |
19,726
+105
| +0.5% | +$442 | ﹤0.01% | 2586 |
|
|
2021
Q4 | $94K | Buy |
+19,621
| New | +$94K | ﹤0.01% | 2508 |
|
|
2019
Q2 | – | Sell |
-2,382,283
| Closed | -$33.8M | – | 1371 |
|
|
2019
Q1 | $33.8M | Sell |
2,382,283
-49,366
| -2% | -$700K | 0.02% | 666 |
|
|
2018
Q4 | $32.9M | Sell |
2,431,649
-291,529
| -11% | -$3.94M | 0.02% | 634 |
|
|
2018
Q3 | $60.4M | Buy |
2,723,178
+2,004,464
| +279% | +$44.5M | 0.03% | 538 |
|
|
2018
Q2 | $11.8M | Buy |
+718,714
| New | +$11.8M | 0.01% | 895 |
|